Cerebral dural sinus thrombosis following cisplatin chemotherapy.
Two patients with cerebral dural sinus thrombosis (CST) following cisplatin therapy are presented. Cisplatin is a well-recognized risk factor for coagulation disorders and thrombosis, but is not known to be associated with CST. Clinicians should be aware of the potential risk for the development of CST following cisplatin therapy.
Karam
Chafic
C
Department of Neurology, Hôtel-Dieu de France Hospital, St-Joseph University, Beirut, Lebanon. chafickaram@hotmail.com
Koussa
Salam
S
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002277:Carcinoma / Q000188:drug therapy; D002945:Cisplatin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012851:Sinus Thrombosis, Intracranial / Q000139:chemically induced*
D000970:Antineoplastic Agents; D002945:Cisplatin